Regulatory Convergence and Cooperation to Improve Access and Quality -Singapore

Regulatory Conference Program Now Available! To kick off 2013, the Asia Regulatory Conference is bringing together global regulatory professionals to share past experiences and new practices. Don’t miss this exciting event to interact with regulatory and other professionals! OVERVIEW Join health authority representatives and industry professionals from Asian and ICH member countries as they continue to discuss regulatory aspects of ICH, APEC and ASEAN convergence initiatives, good regulatory practices, quality and GMP, global drug development, and pharmacovigilance. OBJECTIVES This three-day conference offers a unique opportunity for key stakeholders from health authorities, local and multinational pharmaceutical companies, and clinical research to meet and exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines. This conference will provide a forum to: • Facilitate discussion on common issues in the regulatory and technical areas in Asia • Encourage greater convergence of regulatory requirements in Asia • Strengthen cooperation between Asian regulatory authorities and pharmaceutical industry Day One – Research and Development Day Two – Good Regulatory Practices Day Three – 21st century Global Regulatory Challenges   Register Online     Program Overview     View PDF Program committee chairs Arun Mishra Director Global Regulatory Affairs GlaxoSmithKline, UK John C.W. Lim Chief Executive Officer Health Sciences Authority, Singapore  Who Should Attend Representatives of Health Authorities, Regulatory Affairs professionals, and other professionals involved in or interested in the aspects surrounding registration of medicinal products and regulatory convergence initiatives in Asia. Ministries of Health and Medicines Regulatory Authorities Regulatory Affairs Clinical Research and Development Safety and Pharmacovigilance Clinical Trial and Project Management CMC/Quality (Quality, Manufacturing and Controls)   Register Online     Program Overview     View PDF To know more contact Ellen.Diegel@diahome.org.

Asia Regulatory Conference 2013 - Jan 28-30, Singapore

Asia Regulatory Conference 2013

Jan 28 2013 7:00AM - Jan 30 2013 5:00PM | Raffles City Convention Centre 252 North Bridge Road Singapore 179103 Singapore

Overview

Join health authority representatives and industry professionals from Asian and ICH member countries as they continue to discuss regulatory aspects of ICH, APEC and ASEAN convergence initiatives, good regulatory practices, quality and GMP, global drug development, and pharmacovigilance.

Who Should Attend

Representatives of Health Authorities, Regulatory Affairs professionals, and other professionals involved in or interested in the aspects surrounding registration of medicinal products and regulatory convergence initiatives in Asia.
In particular professionals involved in:

• Ministries of Health and Medicines Regulatory Authorities
• Regulatory Affairs
• Clinical Research and Development Safety and Pharmacovigilance
• Clinical Trial and Project Management
• CMC/Quality (Quality, Manufacturing and Controls)

Learning Objectives

This three-day conference offers a unique opportunity for key stakeholders from health authorities, local and multinational pharmaceutical companies, and clinical research to meet and exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines. This conference will provide a forum to:

• Facilitate discussion on common issues in the regulatory and technical areas in Asia
• Encourage greater convergence of regulatory requirements in Asia
• Strengthen cooperation between Asian regulatory authorities and pharmaceutical industry

Conference speakers will include top-level regulatory authorities from several Asian countries as well as leading experts in the ICH process. In addition, speakers will include representatives of WHO, various regulatory agencies from other regions and the multinational and local pharmaceutical industry.

<< link to program >>